Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter (QASICC-EVA)
Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter: Confirmatory Validation of QASICC Questionnaire
Sponsor: Centre Antoine Lacassagne
Terminated
This trial was terminated. No reason was provided.
Listed as NCT01616537, this NA trial focuses on Malignant Mast Cell Tumors and Solid Organ Sites and remains terminated or withdrawn. Sponsored by Centre Antoine Lacassagne, it has been updated 6 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
Nov 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Antoine Lacassagne
For direct contact, visit the study record on ClinicalTrials.gov .